Confirmation of Safety of COVID 19 mRNA Vaccination for Cancer Patientsijtsrd
Patients in the active phase of treatment for cancer are a population at risk of coronavirus disease 19 COVID 19 with poor prognosis. While a majority of patients treated for cancer expressed their will to be vaccinated as early as December 2020 in a French survey, no data were available in terms of vaccine efficacy and tolerance, because they were excluded from initial registration trials. Several clinical facilities aimed to assess the safety and immunogenicity of the BNT162b2 Pfizer–BioNTech vaccine in patients with cancer. In patients with cancer, one dose of the BNT162b2 vaccine yields poor efficacy. Immunogenicity increased significantly in patients with solid cancer within 2 weeks of a vaccine boost at day 21 after the first dose. However, the anti SARS CoV 2 immune response was lower in patients with solid tumors who were vaccinated a second dose of BNT162b2 vaccine than in healthy individuals. These data support prioritization of patients with cancer for an early day 21 second dose of the BNT162b2 vaccine. Takuma Hayashi | Nobuo Yaegashi | Ikuo Konishi "Confirmation of Safety of COVID-19 mRNA Vaccination for Cancer Patients" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-5 | Issue-4 , June 2021, URL: https://www.ijtsrd.compapers/ijtsrd42563.pdf Paper URL: https://www.ijtsrd.commedicine/other/42563/confirmation-of-safety-of-covid19-mrna-vaccination-for-cancer-patients/takuma-hayashi
Infectious diseases are the second most common cause of death in end-stage renal disease (ESRD) patients. Patients with ESRD are at high risk for several infections, due to exposure to blood products and frequent dialysis. The increased susceptibility to infections among these patients is indicative of a complex and varied state of immunodeficiency manifested by abnormal phagocytosis, T and B lymphocytes abnormalities and impaired response to T cell dependent pathogens such as hepatitis B and influenza viruses. These immunologic abnormalities are complicated by the use of immunosuppressive drugs used to treat and control underlying disease and exacerbated by nutritional deficiency and the dialysis procedure. Though many of these infections can be prevented by appropriate vaccination, the usual schedules of vaccination may be less effective.
The aim of this paper is to review the studies on the use of vaccines in ESRD patients
and summarize the vaccines required in this population.
Confirmation of Safety of COVID 19 mRNA Vaccination for Cancer Patientsijtsrd
Patients in the active phase of treatment for cancer are a population at risk of coronavirus disease 19 COVID 19 with poor prognosis. While a majority of patients treated for cancer expressed their will to be vaccinated as early as December 2020 in a French survey, no data were available in terms of vaccine efficacy and tolerance, because they were excluded from initial registration trials. Several clinical facilities aimed to assess the safety and immunogenicity of the BNT162b2 Pfizer–BioNTech vaccine in patients with cancer. In patients with cancer, one dose of the BNT162b2 vaccine yields poor efficacy. Immunogenicity increased significantly in patients with solid cancer within 2 weeks of a vaccine boost at day 21 after the first dose. However, the anti SARS CoV 2 immune response was lower in patients with solid tumors who were vaccinated a second dose of BNT162b2 vaccine than in healthy individuals. These data support prioritization of patients with cancer for an early day 21 second dose of the BNT162b2 vaccine. Takuma Hayashi | Nobuo Yaegashi | Ikuo Konishi "Confirmation of Safety of COVID-19 mRNA Vaccination for Cancer Patients" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-5 | Issue-4 , June 2021, URL: https://www.ijtsrd.compapers/ijtsrd42563.pdf Paper URL: https://www.ijtsrd.commedicine/other/42563/confirmation-of-safety-of-covid19-mrna-vaccination-for-cancer-patients/takuma-hayashi
Infectious diseases are the second most common cause of death in end-stage renal disease (ESRD) patients. Patients with ESRD are at high risk for several infections, due to exposure to blood products and frequent dialysis. The increased susceptibility to infections among these patients is indicative of a complex and varied state of immunodeficiency manifested by abnormal phagocytosis, T and B lymphocytes abnormalities and impaired response to T cell dependent pathogens such as hepatitis B and influenza viruses. These immunologic abnormalities are complicated by the use of immunosuppressive drugs used to treat and control underlying disease and exacerbated by nutritional deficiency and the dialysis procedure. Though many of these infections can be prevented by appropriate vaccination, the usual schedules of vaccination may be less effective.
The aim of this paper is to review the studies on the use of vaccines in ESRD patients
and summarize the vaccines required in this population.
Vaccination in immunocompromised adults - Slideset by Professor Filippo AnsaldiWAidid
The slideset by Professor Ansaldi explores the heterogeneous world of immunodeficiency with a focus on Primary (PID) and Secundary Immunodeficiencies (SID). The slideset shows the undervaccination in immunocompromised individual, while vaccination in PID and SID may improve quality of life and prognosis, reduce infectious complications and be life saving.
Hepatitis A is an under rated infectious disease in children , with high morbidity and a major cause of fulminant hepatitis in children.There has been a longstanding debate between the LIVE VACCINE FOR HEPATITIS A AND THE KILLED INACTIVATED VACCINE FOR HEPATITIS A. Recent CDC guidelines and INDIAN ACADEMY OF PEDIATRICS GUIDELINES and recent references were studied before making these slides. Hope you find these useful.
Vaccination in immunocompromised adults - Slideset by Professor Filippo AnsaldiWAidid
The slideset by Professor Ansaldi explores the heterogeneous world of immunodeficiency with a focus on Primary (PID) and Secundary Immunodeficiencies (SID). The slideset shows the undervaccination in immunocompromised individual, while vaccination in PID and SID may improve quality of life and prognosis, reduce infectious complications and be life saving.
Hepatitis A is an under rated infectious disease in children , with high morbidity and a major cause of fulminant hepatitis in children.There has been a longstanding debate between the LIVE VACCINE FOR HEPATITIS A AND THE KILLED INACTIVATED VACCINE FOR HEPATITIS A. Recent CDC guidelines and INDIAN ACADEMY OF PEDIATRICS GUIDELINES and recent references were studied before making these slides. Hope you find these useful.
after live donor renal allotransplantation , all patients are vulnerable for infection . vaccination is a good choice to prevent some infectious disease s but immunosuppressive drugs alter the response
Learning Objectives
Define the recurrent infections and differentiate the patient with a primary immunodeficiency (PID) from the "normal person“.
Recognize infectious signs and symptoms, and opportunistic infections of primary immunodeficiency that warrant screening and referral to a specialist.
Understand noninfectious signs and symptoms that should raise concern for primary immunodeficiency.
Determine appropriate testing for patients for whom immunodeficiency is suspected.
Discuss the management of patients with primary immunodeficiency.
Appreciate secondary causes of immunodeficiency
Webinar Series on COVID-19 vaccine: Jointly organized by Malaysian Society of Infection Control and Infectious Diseases (MyICID) & Institute for Clinical Research (ICR), NIH
Speaker: Dr. Rizah Mazzuin Razali, the head of Geriatric Unit and Internal Medicine Physician working in Kuala Lumpur Hospital, Ministry of Health Malaysia.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
13. 13
Renal failure is associated with alterations in the immune
functions. The immunological changes in these patients
include abnormal phagocytosis and B &T-cell response.
Also there are alterations in the chemotaxis mechanism and
abnormalities in the functions of monocytes ¯ophages.
These changes along with frequent exposure to medical
interventions increases the risk of frequency and severity
of infections.
14. 14
End-stage renal disease (ESRD) patients have high rates of
infection related complications.
End-stage renal disease(ESRD) patients have higher mortality
rate compared to those with without ESRD .
These patients visit healthcare providers more often than other
CKD patients providing opportunities for preventive healthcare.
15. 15
People with chronic kidney disease (CKD) are at increased
risk of becoming seriously ill, being hospitalised and even
dying if they contract influenza. There are a number of
reasons for this:
In chronic kidney disease elements of the immune system
that deal with infections like influenza are less active
therefore their recovery is compromised.
16. 16
Renal failure is associated with alterations in the immune
functions. The immunological changes in these patients
include abnormal phagocytosis and B &T-cell response.
Influenza infection predisposes to infection with
pneumococcal bacteria which pose an additional serious
risk to kidney disease sufferers (pneumococcal vaccine is
also important in this group)
Those suffering CKD are likely to have other diagnosed
or undiagnosed risk factors that can lead to poor outcomes
from infection.
17. 17
Patients receiving hemodialysis have higher risk of
hospitalization for infection related complications such
as bacteremia and pneumonia.
Moreover, immunosuppressive therapies also increase
the risk of infections in chronic kidney disease patients.
18. 18
Flu Virus and People with Chronic Kidney
Disease
Children and adults with chronic kidney disease (CKD)
and kidney transplant recipients are high risk groups for
infection from the flu virus and should, therefore,
consider vaccination
19. 19
Recommendations
All patients with chronic kidney disease (CKD) and all
kidney transplant recipients should be advised to receive
annual influenza vaccine.
Household contacts and health care workers should
also be vaccinated annually to decrease the transmission
to high risk CKD or post-transplant patients .
20. 20
Benefits of influenza vaccination in dialysis patients are
documented.
Vaccination against influenza and pneumococcal disease
has shown to be associated with better survival in dialysis
patients with an independent effect of both vaccines on
mortality .
21.
22.
23.
24.
25. If I have a transplant, which vaccines should I avoid?
Inactive vaccines are considered safe for transplant
recipients, but live vaccines should be avoided.
In general, if you have a transplant, you should avoid:
1. Influenza nasal (Flu Mist). The flu shot that is injected is an
inactive vaccine, unlike the nasal mist.
2. Chicken-pox (varicella)
3. Shingles (Herpes Zoster)
4. Measles, Mumps, Rubella (MMR)
5. Yellow Fever
26.
27.
28. 28
Special Considerations in Renal Disease Dialysis
No difference in the serological response to influenza
vaccines was noted in peritoneal dialysis (PD) and
hemodialysis (HD) patients,
The present evidence suggests that both PD and HD
patients should receive the standard annual dose of
the vaccine.
29. 29
Kidney Transplant:
Inactivated influenza vaccine may be given to transplant
recipients despite intensive immunosuppression.
It is best to wait until the first 3–6 months after kidney
transplantation, the period of intense immunosuppression,
before attempting vaccination.
However, inactivated influenza vaccination can be
administered as early as one month after kidney transplant
to time it before onset of the flu season
30. 30
In the event of an outbreak in the community, injectable
vaccine can be given after one month of transplant. Live
vaccines are not advised in this group of patients.
Vaccine should be given prior to the immunosuppressive
therapy if possible. Inactivated vaccines can be given
two weeks or more prior to immunosuppression.
31. 31
Concerns about influenza vaccine triggering an immune
response and increase the risk of acute rejections have
not been substantiated in large scale studies that
demonstrated no increase in acute rejection episodes
when influenza vaccine was used.
In large registry data, influenza vaccine use in transplant
recipients was associated with lower rates of allograft
loss and death.
33. 33
If you have Chronic Kidney Disease at Stage 3, 4 or 5 –
sometimes known as Established Renal Failure (ERF)
you have a greater risk of becoming more seriously ill
from flu than the general population.
If you have had a kidney transplant or are waiting for one
you are more at risk of developing complications if you
catch flu.
34. 34
Evidence suggests people with chronic kidney disease
are 19 times more likely to die from flu complications
than a person who is healthy.
Many of these deaths could have been prevented by
having the flu vaccination.
35. 35
Vaccination is the single most effective way for anyone to
protect themselves against influenza infection.
Influenza vaccination in people with kidney disease has
been shown to reduce infection rates and lower the risk
of hospitalisation and death.
36. 36
Some medications used to treat flu may not be suitable
for people with chronic kidney disease.
Some medications used to treat flu can increase your
risk of heart problems and stroke.
Many people with chronic kidney disease have other long
term conditions such as heart disease or diabetes. These
can also become worse if you catch flu.
56. How influenza virus change
●Type A viruses undergo changes in their surface
antigens or proteins
● Minor changes Antigenic drift
● Major changes Antigenic shift
57. How do yearly epidemics occur?
• Answer: A process called antigenic DRIFT.
• Imperfect “manufacturing” of virus
• Small changes in H and N
• Partial immunity in population
• Incomplete protection; still get sick
• Need new flu vaccine every year
H3N2 H3N2
Immune
System: “Do I
know you? You
look vaguely
familiar!”
58.
59.
60. What drives the occurrence of a pandemic?
Answer:
Instead of antigenic DRIFT occurring,
an antigenic…
…happens.
Immune System:
“Oh my gosh…I
don’t know you at
all!”
H?N?
64. 64
Antigenic drift occurs in both influenza A and influenza
B viruses.
Antigenic drift is the reason that 1 or more of the three virus
strains in the vaccine are updated every year based on
what’s been circulating around the world.
This necessitates the creation of a new seasnal influenza
vaccine every year.
65. 65
Every flu season is different, A flu vaccine is needed every
season for two reasons:
1) The body’s immune response from vaccination declines
over time, so an annual vaccine is needed for optimal
protection , Even if the strains have not changed, getting
influenza vaccine every year is necessary to maximize
protection.
2) Antigenic drift (Flu viruses are constantly changing),which
may occur in one or more influenza virus strains.
66.
67.
68. 68
There are two types of influenza vaccine:
1. Inactivated (killed) vaccine, the “flu shot,” is given
by injection with a needle.
2. Live, attenuated (weakened) influenza vaccine,
the “flu mist,” is sprayed into the nostrils.
73. 73
When should I get Seasonal Influenza Vaccine?
People get vaccinated against influenza as soon as vaccine
becomes available in their community, if possible by October.
In general vaccination before December is best since this timing
ensures that protective antibodies are in place before flu activity
is typically at its highest.
However, flu season can last as late as May so getting vaccinated
later throughout the flu season, even in January or later, could
still provide protective benefit.
74. 74
The effectiveness of influenza vaccine depends primarily
on:
1 . The age and health status of the person getting the
vaccine .
2 . The similarity or "match" between the viruses in the
vaccine and those in circulation
Vaccine effectiveness is not 100%, and some people can still
get the flu after being vaccinated.
75. 75
Does the Flu Vaccine Work?
YES!
Studies have shown that flu vaccine is
70-90% effective
in healthy adults
less than 65 years of age.
76. 76
Adults < 65 years
• 70-90% protection against influenza
Adults > 65 years
• 30 - 40% effective among frail elderly persons
• 50-60% effective in preventing hospitalization
• 80% effective in preventing death
88. 88
▪ Seasonal influenza epidemics can cause febrile illnesses
that range in severity from mild to debilitating and can
lead in some instances to hospitalization and even cause
death, mainly among high-risk groups.
▪ Seasonal influenza is a serious public health problem, it
has been estimated that in developed countries, annual
influenza epidemics infect about 10–20% of the population
each season.
Is Flu Serious ?
89. 89
Worldwide, annual influenza epidemics are estimated to result
in ~1 billion cases of flu, ~3–5 million cases of severe illness
and 300 000–500 000 deaths annually.
Yearly influenza epidemics can seriously affect all populations,
but the highest risk of complications occur among:
oPregnant women
oChildren younger than age 5 years
oAdults aged 65 years or older
oPeople of any age with certain chronic medical conditions,
or weakened immune systems .
Is Flu Serious ?
90.
91. 91
All people 6 months of age and older should get flu vaccine.
92. 92
WHO recommends annual seasonal influenza vaccine for :
(A) Highest priority group:
Pregnant women (at any stage of pregnancy)
(B) 4 other priority groups (in no order of priority) are:
Health-care workers
Children aged 6 months to 5 years
Elderly(≥65 years of age)
Individuals with specific chronic medical condition or immuosuppression
•
95. 95
Health care workers should use every opportunity to
give Inactivated seasonal influenza vaccine to individuals
at risk of serious influenza complications, who have not
been immunized during the current season, even after
influenza activity has been documented in the
community
96. 96
Health-care workers are an important priority group for
influenza vaccination, not only to protect the individual
and maintain health-care services during influenza
epidemics, but also to reduce spread of influenza to
vulnerable patient groups.
Vaccination of HCWs should be considered part of a broader
infection control policy for health-care facilities.
104. 104
Is Flu Vaccine Safe?
YES! The flu shot and nasal spray are very safe , serious
side effects are rare.
Their benefits far outweigh any possible side effects.
105.
106. 106
Other important things in protecting yourself from
getting influenza?
1. Wash your hands often and thoroughly with soap and
warm water, or use a hand sanitizer.
2. Avoid touching your eyes, nose or mouth. You can get
infected by touching something that is contaminated with
influenza and then touching your eyes,nose, or mouth.
3. Avoid close contact with people who are sick.
4. Follow good health habits